EDGAR·FLOW

PLEXUS CORP — Form 10-K

Filed November 19, 2026 · analyzed by the Periodic Agent
10-K — Neutral significance 28/100
What the filing says
Plexus amended its non-recourse receivables purchase agreement with HSBC Bank (China), Xiamen Branch, effective immediately. Total facility limit remains USD 80 million (USD 70M for Xiamen subsidiary, USD 20M for Zhejiang subsidiary); discount rate adjusted to LPR+0.15% for RMB and Applicable Rate+1.1% for USD; 5-year term. Eligible buyers list includes 24 GE entities (medical, industrial, healthcare divisions) with USD 100.5M aggregate credit limits plus RMB 55M, with 120–130 day payment terms. No dollar amount changed materially.
Why this rating

Routine amendment to existing working-capital facility; no facility-size increase. GE concentration risk persists. Immaterial relative to $3.4B market cap.

View original filing on SEC.gov ↗ PLXS · stock on Yahoo Finance ↗

See more from November 19, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.